These medications , Rybelsus and Semaglutide , represent a significant shift in approaches to treating metabolic disorders and, increasingly, excess weight. They operate as GLP-1 GLP-1 analogs , mimicking the https://hamzabtdr201006.wikiexpression.com/6727690/copyright_semaglutide_understanding_the_glp_1_breakthrough